Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature

Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients

(2010) John john puetz   Drug Design Development and Therapy

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression

(2009) M. J. TREUR et al.   HAEMOPHILIA

Prothrombin complex concentrates: a brief review

(2008) C. M. Samama   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors

(2008) T. ABSHIRE et al.   HAEMOPHILIA

Safety Update on Recombinant Factor VIIa in the Treatment of Congenital and Acquired Hemophilia

(2008) Thomas Abshire   SEMINARS IN HEMATOLOGY

Reversal of the inhibitory effect of Fondaparinux on Thrombin generation by rFVIIa, aCCP and PCC

(2008) H. Desmurs-Clavel et al.   THROMBOSIS RESEARCH